Sargent Bickham Lagudis LLC Guardant Health, Inc. Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 100 shares of GH stock, worth $7,020. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$7,020
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GH
# of Institutions
421Shares Held
127MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$854 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$789 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$349 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$338 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$298 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $7.18B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...